Key result
Diltiazem and nicardipine lowered systolic blood pressure during emergence (127 vs 156 mm Hg) and extubation (145 vs 170 mm Hg) in hypertensive patients compared to untreated controls.
Why the study?
Does a combined administration of diltiazem and nicardipine reduce systolic blood pressure during emergence and extubation in preoperative hypertensive and SAH patients?
Cohort
Does a combined administration of diltiazem and nicardipine reduce systolic blood pressure during emergence and extubation in preoperative hypertensive and SAH patients?
The combined administration of diltiazem and nicardipine effectively controls systolic blood pressure during emergence from general anesthesia and extubation without significantly affecting heart rate.
May support combined diltiazem-nicardipine for emergence BP control; leaves open randomized confirmation in SAH and hypertensive patients.
Diltiazem and nicardipine, when injected as a mixture during anesthesia, reduce blood pressure in an additive manner without changing heart rate. The author evaluated the use of this mixture for controlling the blood pressure during emergence from general anesthesia and at extubation. The subjects included 15 preoperative hypertensive (HT) patients who underwent various types of surgery and 18 patients with subarachnoid hemorrhage (SAH) who underwent clipping of a cerebral aneurysm. General anesthesia was maintained with isoflurane or sevoflurane, supplemented with fentanyl. A mixed solution containing 2.5 mg diltiazem plus 0.5 mg nicardipine in 1 mL was injected intermittently every 2 to 4 minutes to bring the blood pressure to its resting level from cessation of inhaled anesthetics to extubation. Untreated patients who underwent similar types of surgery and anesthesia were selected for comparison. The average systolic blood pressure during emergence and at extubation increased to 156 +/- 19 mm Hg (mean +/- standard deviation) and 170 +/- 10 mm Hg in the untreated HT group, and increased to 157 +/- 16 mm Hg and 170 +/- 5mm Hg in the untreated SAH group. Systolic blood pressure was well controlled at 127 +/- 14 mm Hg and 145 +/- 14 mm Hg in the treated HT group with 3.7 +/- 1.9 mL of the mixture, and at 120 +/- 9 mm Hg and 137 +/- 20 mm Hg in the treated SAH group with 7.1 +/- 2.5 mL of the mixture. No significant difference (P < .05) in the heart rate was found between the untreated and the treated HT or SAH groups. Two patients in the treated SAH group exhibited tachycardia. The combined administration of diltiazem and nicardipine can help control blood pressure in patients with a possible HT response to emergence from general anesthesia and extubation.
No takes yet. Share an insight, caveat, or question.
Toshinori Tsutsui (2002) conducted a cohort in Preoperative hypertension and subarachnoid hemorrhage. Combined administration of diltiazem and nicardipine vs. Untreated patients undergoing similar types of surgery and anesthesia was evaluated on Systolic blood pressure during emergence and at extubation. Diltiazem and nicardipine lowered systolic blood pressure during emergence (127 vs 156 mm Hg) and extubation (145 vs 170 mm Hg) in hypertensive patients compared to untreated controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: